AbbVie Inc. logo

AbbVie Inc.

ABBV
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Order
RatiosJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013
Gross Margin
74.74%
71.88%
66.38%
71.82%
70.01%
70.87%
70.94%
66.74%
53.44%
69.42%
67.39%
66.10%
Operating Margin
37.86%
26.60%
12.07%
31.73%
27.98%
26.49%
27.64%
22.73%
16.38%
32.55%
22.64%
31.08%
Pretax Margin
25.18%
6.93%
4.53%
10.08%
12.45%
14.41%
14.84%
14.26%
14.02%
18.82%
3.89%
29.71%
Effective Tax Rate
15.47%
32.92%
73.67%
39.45%
22.40%
24.95%
36.02%
21.82%
8.81%
22.34%
49.26%
10.18%
Net Margin
21.27%
4.63%
1.18%
6.08%
9.64%
10.80%
9.47%
11.12%
12.77%
14.60%
1.96%
26.66%
Current Ratio
0.81x
0.80x
0.72x
0.74x
0.76x
0.65x
0.81x
0.94x
0.96x
0.89x
0.96x
0.93x
Debt to Equity
-23.95x
-21.64x
-52.52x
-995.07x
92.14x
22.62x
19.81x
17.50x
10.23x
9.50x
9.11x
7.82x
Net Debt to Equity
-22.83x
-20.22x
-50.35x
-948.21x
88.60x
21.43x
17.88x
15.26x
9.14x
8.82x
8.61x
7.08x
Asset Turnover
12.57%
10.99%
11.78%
11.24%
9.80%
10.08%
10.19%
8.27%
10.22%
10.24%
9.09%
10.48%
Return on Equity
-61.36%
-10.51%
-7.16%
-679.71%
87.96%
25.71%
20.09%
17.01%
14.66%
15.69%
1.80%
24.64%
Return on Assets
2.67%
0.51%
0.14%
0.68%
0.94%
1.09%
0.97%
0.92%
1.31%
1.50%
0.18%
2.79%